GB0205206D0 - Synthetic peptides - Google Patents

Synthetic peptides

Info

Publication number
GB0205206D0
GB0205206D0 GBGB0205206.6A GB0205206A GB0205206D0 GB 0205206 D0 GB0205206 D0 GB 0205206D0 GB 0205206 A GB0205206 A GB 0205206A GB 0205206 D0 GB0205206 D0 GB 0205206D0
Authority
GB
United Kingdom
Prior art keywords
synthetic peptides
peptides
synthetic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0205206.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxoid Ltd
Original Assignee
Oxoid Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxoid Ltd filed Critical Oxoid Ltd
Priority to GBGB0205206.6A priority Critical patent/GB0205206D0/en
Publication of GB0205206D0 publication Critical patent/GB0205206D0/en
Priority to AU2003215738A priority patent/AU2003215738A1/en
Priority to PCT/GB2003/000953 priority patent/WO2003074555A2/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
GBGB0205206.6A 2002-03-06 2002-03-06 Synthetic peptides Ceased GB0205206D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0205206.6A GB0205206D0 (en) 2002-03-06 2002-03-06 Synthetic peptides
AU2003215738A AU2003215738A1 (en) 2002-03-06 2003-03-06 Synthetic peptides from c. difficile
PCT/GB2003/000953 WO2003074555A2 (en) 2002-03-06 2003-03-06 Synthetic peptides from c. difficile

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0205206.6A GB0205206D0 (en) 2002-03-06 2002-03-06 Synthetic peptides

Publications (1)

Publication Number Publication Date
GB0205206D0 true GB0205206D0 (en) 2002-04-17

Family

ID=9932362

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0205206.6A Ceased GB0205206D0 (en) 2002-03-06 2002-03-06 Synthetic peptides

Country Status (3)

Country Link
AU (1) AU2003215738A1 (en)
GB (1) GB0205206D0 (en)
WO (1) WO2003074555A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5740714B2 (en) 2009-02-20 2015-06-24 ヘルス プロテクション エージェンシー Antibodies against Clostridium difficile toxin
GB0921288D0 (en) 2009-12-04 2010-01-20 Health Prot Agency Therapies for preventing or suppressing clostridium difficile infection
GB201206070D0 (en) 2012-04-04 2012-05-16 Health Prot Agency Clostridium difficile antigens

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5071759A (en) * 1986-05-30 1991-12-10 The United States Of America As Represented By The Secretary Of The Army Hybridoma cell lines and monoclonal antibodies to clostridum difficile toxins A and B
US5919665A (en) * 1989-10-31 1999-07-06 Ophidian Pharmaceuticals, Inc. Vaccine for clostridium botulinum neurotoxin
DE19739685A1 (en) * 1997-09-10 1999-03-11 Eichel Streiber Christoph Von Monoclonal antibodies for the therapy and prophylaxis of diseases caused by Clostridium difficile
JP2002542169A (en) * 1999-04-09 2002-12-10 テクラブ， インコーポレイテッド Recombinant toxin A / toxin B vaccine against Clostridium difficile

Also Published As

Publication number Publication date
WO2003074555A2 (en) 2003-09-12
AU2003215738A1 (en) 2003-09-16
AU2003215738A8 (en) 2003-09-16
WO2003074555A3 (en) 2004-03-04

Similar Documents

Publication Publication Date Title
AU2003290563A8 (en) Leptin-related peptides
GB0324265D0 (en) Peptide
EP1614695A4 (en) Polypeptide
GB0218977D0 (en) Polypeptide
GB0205206D0 (en) Synthetic peptides
GB0202275D0 (en) Peptide
GB0223193D0 (en) Polypeptide
GB0201808D0 (en) Protein
AU2003220217A8 (en) Identifying peptide modifications
PL376318A1 (en) Protein modification
AU2003278718A8 (en) Stars-a muscle-specification-binding protein
GB0210746D0 (en) Peptide
GB0219980D0 (en) Peptides
GB0208925D0 (en) Polypeptide
GB0210913D0 (en) Synthetic peptide
GB0224896D0 (en) Peptides
GB0213246D0 (en) Peptides
AU2003303642A8 (en) Synthetic neutropoiesis-stimulating proteins
GB0203883D0 (en) Peptide
GB0202748D0 (en) Protein
GB0324466D0 (en) Peptides
GB0326303D0 (en) Peptides
GB0203882D0 (en) Peptide variants
GB0230144D0 (en) Peptidic compounds
GB0222181D0 (en) Polypeptide

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)